S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

CYCN Cyclerion Therapeutics Inc

2.82

0.00 (0.00%)

Feb 23 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Cyclerion Therapeutics (NASDAQ:CYCN)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Cyclerion Therapeutics Charts.

Cyclerion Therapeutics (NASDAQ:CYCN)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Cyclerion Therapeutics Charts.

Cyclerion Therapeutics Inc News

Form EFFECT - Notice of Effectiveness
Wednesday 12 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Tuesday 4 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 17 December 2024 (2 months ago) • Edgar (US Regulatory)

Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth
Tuesday 17 December 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 August 2024 (7 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 7 August 2024 (7 months ago) • Edgar (US Regulatory)

Regina Graul, Ph.D., Promoted to Chief Executive Officer
Wednesday 7 August 2024 (7 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 7 August 2024 (7 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 14 June 2024 (8 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 7 May 2024 (10 months ago) • Edgar (US Regulatory)

More Cyclerion Therapeutics Inc News Articles

Accredited Solutions (PK)

Northwest Biotherapeutics (QB)

North Bay Resources (PK)

Anavex Life Sciences

Bioelectronics (PK)

Rennova Health (CE)

Elite Pharmaceuticals (QB)

Fannie Mae (QB)

Intergrated Cannabis Sol... (PK)

Digital Brand Media and ... (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions